Reposted by Ludanto the Red Dalmatian

So, not COVID related but, this is REALLY exciting news. Midstage trial results show Moderna’s cancer vaccine mRNA-4157 in combination with Merck’s KEYTRUDA reduced the risk of death or relapse in patients with melanoma by HALF after roughly THREE years! Let’s talk about that! 🧵⬇️🧪